Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Vaccines for Covid-19: A Systematic Review of Feasibility and Effectiveness Publisher



Mehraeen E1 ; Dadras O2 ; Afsahi AM3 ; Karimi A4 ; Pour MM1 ; Mirzapour P1 ; Barzegary A5 ; Behnezhad F6 ; Habibi P7 ; Salehi MA7 ; Vahedi F4 ; Heydari M1 ; Kianzad S8 ; Moradmandbadie B9 Show All Authors
Authors
  1. Mehraeen E1
  2. Dadras O2
  3. Afsahi AM3
  4. Karimi A4
  5. Pour MM1
  6. Mirzapour P1
  7. Barzegary A5
  8. Behnezhad F6
  9. Habibi P7
  10. Salehi MA7
  11. Vahedi F4
  12. Heydari M1
  13. Kianzad S8
  14. Moradmandbadie B9
  15. Javaherian M10
  16. Alinaghi SAS7
  17. Sabatier JM11

Source: Infectious Disorders - Drug Targets Published:2022


Abstract

; Introduction: Many potential vaccines for COVID-19 are being studied and developed. Several studies have reported on the safety and efficacy of these vaccines. This systematic review aimed to report on the current evidence concerning the feasibility and effectiveness of vaccines for COVID-19. Methods: A systematic search was carried out utilizing the keywords in the online databases, including Scopus, Web of Science, PubMed, Embase, and Cochrane. We included both human and non-human studies because of the vaccine novelty, limiting our ability to include sufficient human studies. Results: This review showed several SARS-CoV-2 vaccines to be currently under development using different platforms, including eight vaccines that are adenovirus-based vectors, six vaccines that are RNA-based formulations, one vaccine being DNA-based formulation, and other vaccines using other platforms, including lipid nanoparticles. Although the safety and efficacy profiles of these vaccines are still under debate, some countries have allowed for emergency use of some vaccines in at-risk populations, such as healthcare workers and the elderly. Conclusion: It is crucial to gather as much clinically relevant evidence as possible regarding the immunogenicity, efficacy, and safety profiles of available vaccines and adhere wisely to CDC protocols and guidelines for vaccine production. © 2022 Bentham Science Publishers.
Related Docs
View other Related Docs
1. Severe Acute Respiratory Syndrome-Coronavirus-2 Spike (S) Protein Based Vaccine Candidates: State of the Art and Future Prospects, Reviews in Medical Virology (2021)
2. Recent Developments in Sars-Cov-2 Vaccines: A Systematic Review of the Current Studies, Reviews in Medical Virology (2023)
3. Sars-Cov-2: Current Trends in Emerging Variants, Pathogenesis, Immune Responses, Potential Therapeutic, and Vaccine Development Strategies, International Immunopharmacology (2021)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (3)
Shekoufeh Nikfar (1)
Other Related Docs
4. State-Of-The-Art of Nanodiagnostics and Nanotherapeutics Against Sars-Cov-2, ACS Applied Materials and Interfaces (2021)
5. A Comparison Between Sars-Cov-1 and Sars-Cov2: An Update on Current Covid-19 Vaccines, DARU# Journal of Pharmaceutical Sciences (2022)
6. Genetic Susceptibility of Covid-19: A Systematic Review of Current Evidence, European Journal of Medical Research (2021)
7. Covid-19 Vaccinations: The Unknowns, Challenges, and Hopes, Journal of Medical Virology (2022)
8. Characterization of Stability, Safety and Immunogenicity of the Mrna Lipid Nanoparticle Vaccine Iribovax® Against Covid-19 in Nonhuman Primates, Journal of Controlled Release (2023)
9. T Helper Type (Th1/Th2) Responses to Sars-Cov-2 and Influenza a (H1n1) Virus: From Cytokines Produced to Immune Responses, Transplant Immunology (2022)
10. An Overview on the Treatments and Prevention Against Covid-19, Virology Journal (2023)
11. The Chimera of S1 and N Proteins of Sars-Cov-2: Can It Be a Potential Vaccine Candidate for Covid-19?, Expert Review of Vaccines (2022)
12. Vlp-Based Covid-19 Vaccines: An Adaptable Technology Against the Threat of New Variants, Vaccines (2021)
13. Current Advances and Challenges in Covid-19 Vaccine Development: From Conventional Vaccines to Next-Generation Vaccine Platforms, Molecular Biology Reports (2022)
14. Covid-19: A Review on Treatment Strategies and Candidate Vaccines, Scientific Journal of Kurdistan University of Medical Sciences (2021)
15. Covid-19: A Systematic Review and Update on Prevention, Diagnosis, and Treatment, MedComm (2022)
16. Safety and Immunogenicity of a Recombinant Receptor-Binding Domain-Based Protein Subunit Vaccine (Noora Vaccine™) Against Covid-19 in Adults: A Randomized, Double-Blind, Placebo-Controlled, Phase 1 Trial, Journal of Medical Virology (2023)
17. Overview of the Current Promising Approaches for the Development of an Effective Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2) Vaccine, International Immunopharmacology (2020)
18. Emerging Advances of Nanotechnology in Drug and Vaccine Delivery Against Viral Associated Respiratory Infectious Diseases (Varid), International Journal of Molecular Sciences (2021)
19. Review on Approved and Inprogress Covid-19 Vaccines, Iranian Journal of Pharmaceutical Research (2022)
20. Appraisal of Sars-Cov-2 Mutations and Their Impact on Vaccination Efficacy: An Overview, Journal of Diabetes and Metabolic Disorders (2022)